在修改后的烟支架后,冠状动脉重新进入自我扩张的跨导管内门中
Won-Keun Kim1,2,3, Chris Frawley4, Efstratios I Charitos2
1Department of Cardiology, Kerckhoff Heart Center, Bad Nauheim, Germany, and German Center for Cardiovascular Research, Partner Site Rhine-Main, Frankfurt am Main, Germany.
JACC. Case reports
|January 11, 2024
概括
一种新的烟支架技术成功地防止了在门内透导管大动脉门更换过程中冠状动脉阻塞. 这种方法确保了安全的重复处理,并防止了支架-小册子相互作用,改善了手术结果.
科学领域:
- 心血管干预 心血管干预
- 医疗器械技术 医疗器械技术
- 结构性心脏病 结构性心脏病
背景情况:
- 过导管大动脉置换 (TAVR) 是对大动脉狭窄的常见手术.
- 内TAVR (ViV-TAVR) 用于退化的生物假体.
- 冠状动脉阻塞是ViV-TAVR期间罕见但严重的并发症.
相关概念视频
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...


